LATEST NEWS April 19 2022 Tn Antigen Peter Mac Development Clinical Study Results February 28 2022 Regulatory Approval to sell Xprecia PrimeTM in 32 countries in Europe January 18 2022 UBI launches new Sentia Malic Acid Test December 24 2021 UBI Signs new technology licensing deal to commercialise SARS-CoV-2 N- Protein test November 11 2021 UBI signs Master collaboration Agreement with Mayo Clinic October 4 2021 UBI signs major French distribution deal September 20 2021 UBI partners with world leader for cancer biosensor trials September 15 2021 Peter Mac – Tn Antigen Cancer biosensor trial August 4 2021 Rapid cancer detection from a single drop of blood June 22 2021 ‘Miracle protein’ biosensor set to transform early cancer detection April 29 2021 UBI signs New Zealand distribution deal for Sentia April 26 2021 UBI signs South Africa distribution deal Page 1 Page 2 Page 3 … Page 6 Next »
